Evan Mayo-Wilson, DPhil, MPA
I am an Associate Professor in the Department of Epidemiology at the UNC Gillings School of Global Public Health.
My research focuses on the benefits and harms of health interventions, artificial intelligence to assess and improve clinical trials and systematic reviews, and reporting standards that increase research transparency and openness.
I am a principal investigator of studies that use artificial intelligence to extract and compare the methods and results of intervention research. I also serve as Co-Scientific Director for peer review of Patient-Centered Outcomes Research Institute (PCORI) Final Research Reports. I am a member of the Cochrane Methods Executive, Associate Convenor of the Cochrane Adverse Events Methods Group, and member of the American Psychological Association Open Science and Methodology Expert Panel. I have authored multiple guidelines for reporting clinical trials and systematic reviews, and I am one of five members of the PRISMA Executive, which is responsible for maintaining guidelines for reporting systematic reviews. In 2025, Nature ranked PRISMA 2020 among the 25 most-cited papers of the twenty-first century.
Research
Current grants
Improving results and conclusions about harms in systematic reviews of drugs (AHRQ R01HS029877)
Objective: Examine whether information about safety in systematic reviews is consistent, and whether systematic reviews address safety concerns identified in real-world evidence and drug labels.
Computational methods, resources, and tools to assess transparency and rigor of randomized clinical trials (NLM R01LM014079)
Objective: Develop automated methods to identify methods described in reports of clinical trials, assess adherence to reporting guidelines, and conduct meta-research.
Previous support
- Agency for Healthcare Research and Quality (AHRQ)
- Arnold Ventures (Laura and John Arnold Foundation)
- Economic and Social Research Council, UK (ESRC)
- National Institute for Health and Care Excellence, UK (NICE)
- National Institutes of Health (NIH)
- Patient Centered Outcomes Research Institute (PCORI)
- Robert Wood Johnson Foundation (RWJF)
- United States Food and Drug Administration (FDA)
Teaching
I advise PhD students in epidemiology. I welcome students interested in the program to email me.
I teach Systematic Review (EPID 702) in the Spring semester. In the Fall semester, I teach the Pharmacoepidemiology Seminar (EPID 893) and am a small group instructor for Epidemiologic Research Methods (EPID 726). I also teach at the Summer Institute on Randomized Behavioral Clinical Trials (sponsored by NIH).
Service
Current
-
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Executive Committee
-
American Psychological Association Open Science and Methodology Expert Panel
Previous
-
National Academies of Sciences, Engineering, and Medicine (NASEM) committees
-
Evidence review of the adverse effects of COVID-19 vaccination and intramuscular vaccine administration
-
Review of Department of Veterans Affairs monograph on health economic effects of service dogs for veterans with post traumatic stress disorder
-
Review of Department of Veterans Affairs monograph (No. 1) on potential effects of service and emotional support dogs on post-traumatic stress disorder (therapeutic effects)
-
-
Transparency and Openness Promotion (TOP) Guidelines Advisory Committee
-
American Psychological Association (APA) Advisory Steering Committee for Development of Clinical Practice Guidelines
-
NIH Science of Behavior Change (SOBC) Good Clinical Practice Workshop (to improve policies and procedures for reporting the methods and results of clinical trials of behavioral interventions)
-
NIH Office of Behavioral and Social Sciences Research (OBSSR) Working Group for Comparator Selection in Behavioral and Social Science Trials
Publications
2026
Outcome reporting in cohort studies of interventionsYing X, Mayo-Wilson E. BMJ 393:s922. PMID: 42203256.
An automated approach to improve clinical trial registration and to identify outcome changes on ClinicalTrials.govYing X, Ninan K, Oberste JP, Vorland CJ, Li T, Brown AW, Menke JD, Qureshi R, DeVito NJ, Page MJ, McKenzie JE, Saldanha IJ, Zhang S, Butcher NJ, Offringa M, Cummins J, Kilicoglu H, Mayo-Wilson E. NPJ Digit Med. DOI: 10.1038/s41746-026-03045-y. [Protocol on MetaArXiv]
Guidance for defining outcomes in clinical trialsYing X, Li T, McKenzie JE, Page MJ, Ninan K, Oberste JP, Vorland CJ, Brown AW, Qureshi R, DeVito NJ, Saldanha IJ, Offringa M, Butcher NJ, Zhang S, Nguyen PY, Menke JD, Lai VKW, Kilicoglu H, Mayo-Wilson E. PLoS Med 23(10):e1005275. PMID: 42905861. [Preprint on MetaArXiv]
Outcome definitions in clinical trial registrations: A cross-sectional studyNinan K, Oberste JP, Ying X, DeVito NJ, Li T, Blanco D, Grana C, Boutron I, Baldwin-SoRelle C, Kilicoglu H, Mayo-Wilson E. MetaArXiv. DOI: 10.31222/osf.io/hkudx_v1. Accepted at JAMA Netw Open. [Protocol on OSF; OSF archive includes data and code]
PRISMA-trAIce: A name without endorsementMoher D, Page MJ, McKenzie JE, Takwoingi Y, Mayo-Wilson E. JMIR AI 5:e104210. PMID: 42612062.
Evaluation of automated assessments of systematic review adherence to the PRISMA 2020 statement: Study protocolPage MJ, Mayo-Wilson E, Zeng M, Clark DPQ, Hamilton DG, Nguyen PY, Nussbaumer-Streit B, Ying X, Kilicoglu H, McKenzie JE. F1000Res 15:665. DOI: 10.12688/f1000research.180216.1.
The PRISMA family of reporting guidelines for systematic reviews: Initiatives to better support development and implementation, and future challenges and opportunitiesMcKenzie JE, Mayo-Wilson E, Brennan SE, Hamilton DG, Takwoingi Y, Moher D, Page MJ. MetaArXiv. DOI: 10.31222/osf.io/ydnt7_v1.
Study design indexing in transition: A focused comparison of manual NLM indexing versus transformer-based automated modelsDas P, Schneider J, Mayo-Wilson E, Kilicoglu H, Menke JD, Nam D, Ninan K, Oberste JP, Troy AM, Ying X, Holt AW, Smalheiser NR. JAMIA Open 9(5):ooag197. PMID: 42960168. [Preprint on medRxiv; Protocol on OSF; Data on Illinois Data Bank]
Artificial intelligence tools for automating assessments of reporting guideline adherence: A protocol for a systematic reviewZeng M, Liu S, Clark DPQ, McDonald S, Mayo-Wilson E, Ying X, Menke J, Lan M, Jiang L, Ninan K, Oberste JP, McKenzie JE, Kilicoglu H, Page MJ. F1000Res 15:626. DOI: 10.12688/f1000research.179775.2. [Zenodo archive includes research materials]
Descriptive epidemiology of musculoskeletal injuries presenting to an embedded Holistic Health and Fitness (H2F) team in a United States Army Stryker Brigade, October 2021-September 2022Naylor JA, Jonsson Funk M, Ranapurwala SI, Canham-Chervak M, Mayo-Wilson E, Bruno MK, Olivarez CV, Marshall SW. Mil Med 191(9-10):e2057-e2065. PMID: 41641596.
TOP 2025: An update to the Transparency and Openness Promotion GuidelinesGrant S, Corker KS, Mellor D, Stewart SLK, Mayo-Wilson E, Cashin AG, Lagisz M, Moher D, Umpierre D, Barbour V, Buck S, Collins GS, Hazlett HF, Hrynaszkiewicz I, Lee CJ, Parker TH, Rethlefsen ML, Toomey E, Nosek BA, TOP Advisory Board. Res Integr Peer Rev 11(1):40. PMID: 42557573. [Preprint on MetaArXiv; OSF archive includes research materials]
Harm outcomes applicable for most meta-analyses of randomized trials of biomedical interventions: A key concept in clinical epidemiologyChristensen R, Berthelsen DB, Tugwell P, Golder S, Qureshi R, Mayo-Wilson E, Simon LS, Kwong J, Williamson PR, Vohra S. J Clin Epidemiol 194:112218. PMID: 41802580.
Time-to-expiration for evidence bodies of medication harms (TIME): Survival analysis from a retrospective cohortWang X, Furuya-Kanamori L, Doi SA, Gu Z, Loke Y, Li S, Mayo-Wilson E, Lin L, Golder S, Chu H, Vohra S, Guo X, Xu C. BMC Med. DOI: 10.1186/s12916-026-05296-8.
SPIRIT-CONSORT-ELM: Element-level annotated dataset and large language model approach for assessing randomized controlled trial reportingJiang L, Ying X, Brown AW, Lan M, Song W, Menke JD, Vorland CJ, Mayo-Wilson E, Kilicoglu H. NPJ Digit Med. DOI: 10.1038/s41746-026-03318-6. [Preprint on medRxiv; OSF archive includes data and code]
Automated assessment of the trustworthiness of biomedical publications: A protocol for a scoping reviewGuerra E, Menke JD, Bernabé C, Ying X, Vorland CJ, Brown AW, Qureshi R, Mayo-Wilson E, Kilicoglu H. MetaArXiv. DOI: 10.31222/osf.io/yph8c_v1.
Towards understanding the disease landscape of clinical trials in Germany: Ontology and embedding-based pipelines versus large language models for ICD-10 harmonizationNdabashinze R, Franzen D, Kozuch E, Aagerup J, Fink A, Samruddhi YS, Hunter K, Mayo-Wilson E, Ying X, Kilicoglu H, Schorr SG, Seidler AL. medRxiv. DOI: 10.64898/2026.08.04.26359616. [Protocol on OSF]
Evaluating data extraction error by a large language model from randomised controlled trials: A large-scale empirical studyFan S, Chen M, Doi SA, Ye Z, Peng Z, Tian Y, Zhang C, Furuya-Kanamori L, Lin L, Mayo-Wilson E, Murad MH, Meng X, Xu C. BMJ Evid Based Med 31(5):324-331. PMID: 42055792.
The Trial Bank initiative to promote trustworthy living evidence for medication safety (PROMISE) of children: Design and pilot validationXu C, Doi SA, Vohra S, Furuya-Kanamori L, Wang Y, Tang L, Tian Y, Fan S, Peng Z, Mayo-Wilson E, Lin L, Chu H, Murad MH, Yu T, Li S, Chen Y, Golder S, Loke Y, Clark J, Glasziou P, Du L, Lin H, Gu Z, PROMISE Collaborative Research Network. BMC Med 24(1):181. PMID: 41723462. [OSF archive includes data]
Methods of engaging interest-holders in healthcare evidence syntheses: A scoping reviewTodhunter-Brown A, Petkovic J, Chang C, Griebler U, Hannigan A, Hilgart J, Hussain B, Jull J, Koscher-Kien C, Ledinger D, Nussbaumer-Streit B, Oloyede O, Tomlinson E, Dawson S, Dewidar O, Grant S, Lytvyn L, Concannon TW, Dans L, John D, Jordan Z, Mayo-Wilson E, McCutcheon C, Nonino F, Pollock D, Toupin April K, Campbell P, Khabsa J, Magwood O, Welch V, Tugwell P. Cochrane Evid Synth Methods 4(1):e70066. PMID: 41573527. [Protocol on OSF]
2025
Complete reporting of clinical trials requires more than journal articlesMayo-Wilson E. BMJ 389:r494. PMID: 40228826.
Consistent and precise description of research outputs could improve implementation of open scienceMayo-Wilson E, Grant SP, Corker KS, Moher D. Adv Methods Pract Psychol Sci 8(4):25152459251375445. DOI: 10.1177/25152459251375445. [Preprint on MetaArXiv]
Determining sample size for pilot trials: A tutorialYing X, Freedland KE, Powell LH, Stuart EA, Ehrhardt S, Mayo-Wilson E. BMJ 390:e083405. PMID: 40780848.
Weighted corrected covered area (wCCA): A measure of informational overlap among reviewsYing X, Bougioukas KI, Pieper D, Mayo-Wilson E. Res Synth Methods 16(4):701-708. PMID: 41626914.
Chapter 12: Systems of evidence in health psychology. In: Smith T, Anderson NB, eds. APA Handbook of Health Psychology, Volume 1: Foundations and Context of Health PsychologyCzajkowski S, Davidson K, Freedland K, Mayo-Wilson E (order of authorship is alphabetical). American Psychological Association: Washington, DC. pp. 269-292. ISBN: 978-1-4338-3672-5. DOI: 10.1037/0000394-012.
Musculoskeletal injury (MSKI) outcome definitions as reported in military population research from 2015-2025: A scoping review protocolNaylor JA, Mayo-Wilson E, Martin CL, Baldwin-SoRelle C, Ranapurwala S, Canham-Chervak M, Jonsson Funk M, Marshall SW. OSF Preprints. DOI: 10.31219/osf.io/nw7fy_v1.
SPIRIT-CONSORT-TM: A corpus for assessing transparency of clinical trial protocol and results publicationsJiang L, Vorland CJ, Ying X, Brown AW, Menke JD, Hong G, Lan M, Mayo-Wilson E, Kilicoglu H. Sci Data 12(1):355. PMID: 40021657. [Preprint on medRxiv; OSF archive includes data; GitHub includes code]
2024
Publication of results of registered trials with published study protocols, 2011-2022Vorland CJ, Brown AW, Kilicoglu H, Ying X, Mayo-Wilson E. JAMA Netw Open 7(1):e2350688. PMID: 38190185. [OSF archive includes data and code]
Studying harms of interventions with an equity lens in randomized trialsLi T, Mayo-Wilson E, Shaughnessy D, Qureshi R. Trials 25(1):403. PMID: 38902776.
Development and evaluation of a framework for identifying and addressing spin for harms in systematic reviews of interventionsQureshi R, Naaman K, Quan NG, Mayo-Wilson E, Page MJ, Cornelius V, Chou R, Boutron I, Golder S, Bero L, Doshi P, Vassar M, Meursinge Reynders R, Li T. Ann Intern Med 177(8):1089-1098. PMID: 39008854. [Online supplements include protocol and research materials]
Proposal to develop a clinical practice guideline on emotion regulation: Final reportMuran JC, Teachman B, Aldao A, Ehrenreich-May J, Fonagy P, Greenberg L, Gross J, Magnavita J, Mayo-Wilson E, McMain S, Soto JA, Bufka L, Halfond R, Kurtzman H, Marzalik J. PsyArXiv. DOI: 10.31234/osf.io/g627d.
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Elsman EBM, Mokkink LB, Terwee CB, Beaton D, Gagnier JJ, Tricco AC, Baba A, Butcher NJ, Smith M, Hofstetter C, Aiyegbusi OL, Berardi A, Farmer J, Haywood KL, Krause KR, Markham S, Mayo-Wilson E, Mehdipour A, Ricketts J, Szatmari P, Touma Z, Moher D, Offringa M. J Clin Epidemiol 173:111422. PMID: 38849061.
This article was published simultaneously in:
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Elsman EBM, Mokkink LB, Terwee CB, Beaton D, Gagnier JJ, Tricco AC, Baba A, Butcher NJ, Smith M, Hofstetter C, Aiyegbusi OL, Berardi A, Farmer J, Haywood KL, Krause KR, Markham S, Mayo-Wilson E, Mehdipour A, Ricketts J, Szatmari P, Touma Z, Moher D, Offringa M. Qual Life Res 33(8):2029-2046. PMID: 38980635.
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Elsman EBM, Mokkink LB, Terwee CB, Beaton D, Gagnier JJ, Tricco AC, Baba A, Butcher NJ, Smith M, Hofstetter C, Aiyegbusi OL, Berardi A, Farmer J, Haywood KL, Krause KR, Markham S, Mayo-Wilson E, Mehdipour A, Ricketts J, Szatmari P, Touma Z, Moher D, Offringa M. J Patient Rep Outcomes 8(1):64. PMID: 38977535.
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024Elsman EBM, Mokkink LB, Terwee CB, Beaton D, Gagnier JJ, Tricco AC, Baba A, Butcher NJ, Smith M, Hofstetter C, Aiyegbusi OL, Berardi A, Farmer J, Haywood KL, Krause KR, Markham S, Mayo-Wilson E, Mehdipour A, Ricketts J, Szatmari P, Touma Z, Moher D, Offringa M. Health Qual Life Outcomes 22(1):48. PMID: 38978063.
A guide for social science journal editors on easing into open scienceSilverstein P, Elman C, Montoya A, McGillivray B, Pennington CR, Harrison CH, Steltenpohl CN, Röer JP, Corker KS, Charron LM, Elsherif M, Malicki M, Hayes-Harb R, Grinschgl S, Neal T, Evans TR, Karhulahti VM, Krenzer WLD, Belaus A, Moreau D, Burin DI, Chin E, Plomp E, Mayo-Wilson E, Lyle J, Adler JM, Bottesini JG, Lawson KM, Schmidt K, Reneau K, Vilhuber L, Waltman L, Gernsbacher MA, Plonski PE, Ghai S, Grant S, Christian TM, Ngiam W, Syed M. Res Integr Peer Rev 9(1):2. PMID: 38360805. [Preprint on OSF Preprints]
Evidence review of the adverse effects of COVID-19 vaccination and intramuscular vaccine administrationNational Academies of Sciences, Engineering, and Medicine. Washington, DC: The National Academies Press. PMID: 39312602.
2023
Harms were detected but not reported in six clinical trials of gabapentinMayo-Wilson E, Qureshi R, Hong H, Chen X, Li T. J Clin Epidemiol 164:76-87. PMID: 37871835. [Published protocol; Preprint on MetaArXiv; OSF archive includes data and code]
Conducting separate reviews of benefits and harms could improve systematic reviews and meta-analysesMayo-Wilson E, Qureshi R, Li T. Syst Rev 12(1):67. PMID: 37061724.
Open science standards at journals that inform evidence-based policyGrant S, Mayo-Wilson E (joint first authors), Kianersi S, Naaman K, Henschel B. Prev Sci 24(7):1275-1291. PMID: 37178346. [Published protocol; Preprint on MetaArXiv; OSF archive includes data and code]
Evaluating implementation of the Transparency and Openness Promotion Guidelines: Reliability of instruments to assess journal policies, procedures, and practicesKianersi S, Grant S, Naaman K, Henschel B, Mellor D, Apte S, Deyoe JE, Eze P, Huo C, Lavender BL, Taschanchai N, Zhang X, Mayo-Wilson E. Adv Methods Pract Psychol Sci 6(1):25152459221149735. DOI: 10.1177/25152459221149735. [Published protocol; Preprint on MetaArXiv; OSF archive includes data and code]
Exploring enablers and barriers to implementing the Transparency and Openness Promotion Guidelines: A theory-based survey of journal editorsNaaman K, Grant S, Kianersi S, Supplee L, Henschel B, Mayo-Wilson E. R Soc Open Sci 10(2):221093. PMID: 36756061. [Preprint on MetaArXiv; OSF archive includes data and code]
Adding standards and procedures to the What Works Clearinghouse handbook on the transparency, openness, and reproducibility of effectiveness research on education practices, products, programs, and policiesGrant SP, Mayo-Wilson E, Supplee LH. MetaArXiv. DOI: 10.31222/osf.io/nra5v.
Methodology reporting improved over time in 176,469 randomized controlled trialsKilicoglu H, Jiang L, Hoang L, Mayo-Wilson E, Vinkers CH, Otte WM. J Clin Epidemiol 162:19-28. PMID: 37562729. [GitHub sites include trial data and data from model predictions used in the analysis]
CONSORT Harms 2022 statement, explanation, and elaboration: Updated guideline for the reporting of harms in randomised trialsJunqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S on behalf of the CONSORT Harms Group. BMJ 381:e073725. PMID: 37094878.
This article was published simultaneously in:
- CONSORT Harms 2022 statement, explanation, and elaboration: Updated guideline for the reporting of harms in randomized trialsJunqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S on behalf of the CONSORT Harms Group. J Clin Epidemiol 158:149-165. PMID: 37100738.
ROB-ME: A tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysisPage MJ, Sterne JAC, Boutron I, Hróbjartsson A, Kirkham JJ, Li T, Lundh A, Mayo-Wilson E, McKenzie JE, Stewart LA, Sutton AJ, Bero L, Dunn AG, Dwan K, Elbers RG, Kanukula R, Meerpohl JJ, Turner EH, Higgins JPT. BMJ 383:e076754. PMID: 37984978.
Toward more rigorous and informative nutritional epidemiology: The rational space between dismissal and defense of the status quoBrown AW, Aslibekyan S, Bier D, Ferreira da Silva R, Hoover A, Klurfeld DM, Loken E, Mayo-Wilson E, Menachemi N, Pavela G, Quinn PD, Schoeller D, Tekwe C, Valdez D, Vorland CJ, Whigham LD, Allison DB. Crit Rev Food Sci Nutr 63(18):3150-3167. PMID: 34678079.
Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 yearsImdad A, Rogner J, Sherwani RN, Sidhu J, Regan A, Haykal MR, Tsistinas O, Smith A, Chan XHS, Mayo-Wilson E, Bhutta ZA. Cochrane Database Syst Rev 3:CD009384. PMID: 36994923. [Updates previous version; Published protocol]
Reporting of factorial randomized trials: Extension of the CONSORT 2010 statementKahan BC, Hall SS, Beller EM, Birchenall M, Chan AW, Elbourne D, Little P, Fletcher J, Golub RM, Goulao B, Hopewell S, Islam N, Zwarenstein M, Juszczak E, Montgomery AA, Delphi study members (contributor). JAMA 330(21):2106-2114. PMID: 38051324.
Consensus statement for protocols of factorial randomized trials: Extension of the SPIRIT 2013 statementKahan BC, Hall SS, Beller EM, Birchenall M, Elbourne D, Juszczak E, Little P, Fletcher J, Golub RM, Goulao B, Hopewell S, Islam N, Zwarenstein M, Chan AW, Montgomery AA, Delphi study members (contributor). JAMA Netw Open 6(12):e2346121. PMID: 38051535.
2022
Clearinghouse standards of evidence on the transparency, openness, and reproducibility of intervention evaluationsMayo-Wilson E, Grant SP, Supplee LH. Prev Sci 23(5):774-786. PMID: 34357509. [Preprint on MetaArXiv; OSF archive includes data and code]
Modern meta-analytic methods in prevention science: Introduction to the special issueTanner-Smith EE, Grant S, Mayo-Wilson E. Prev Sci 23(3):341-345. PMID: 35171463.
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of ageImdad A, Mayo-Wilson E, Haykal MR, Regan A, Sidhu J, Smith A, Bhutta ZA. Cochrane Database Syst Rev 3:CD008524. PMID: 35294044. [Updates previous version; Published protocol]
Harms in systematic reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harmsQureshi R, Mayo-Wilson E, Rittiphairoj T, McAdams-DeMarco M, Guallar E, Li T. J Clin Epidemiol 143:224-241. PMID: 34742790. [Preprint on OSF Preprints; OSF archive includes data and code]
Harms in systematic reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentinQureshi R, Mayo-Wilson E, Rittiphairoj T, McAdams-DeMarco M, Guallar E, Li T. J Clin Epidemiol 143:212-223. PMID: 34742789. [Preprint on OSF Preprints; OSF archive includes data and code]
Harms in systematic reviews Paper 1: An introduction to research on harmsQureshi R, Mayo-Wilson E, Li T. J Clin Epidemiol 143:186-196. PMID: 34742788. [Preprint on OSF Preprints]
Comparing the value of data visualization methods for communicating harms in clinical trialsQureshi R, Chen X, Görg C, Mayo-Wilson E, Dickinson S, Golzarri-Arroyo L, Hong H, Phillips R, Cornelius V, McAdams-DeMarco M, Guallar E, Li T. Epidemiol Rev 44(1):55-66. PMID: 36065832. [Online supplement includes code and research materials; GitHub includes code]
Designing clinically useful psychopharmacological trials: Challenges and ways forwardChevance A, Ravaud P, Cornelius V, Mayo-Wilson E, Furukawa TA. Lancet Psychiatry 9(7):584-594. PMID: 35525252.
Transparent, open, and reproducible prevention scienceGrant S, Wendt KE, Leadbeater BJ, Supplee LH, Mayo-Wilson E, Gardner F, Bradshaw CP. Prev Sci 23(5):701-722. PMID: 35175501. [Preprint on MetaArXiv]
Guidelines for reporting outcomes in trial reports: The CONSORT-Outcomes 2022 extensionButcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F, Grimshaw JM, Kelly LE, Saeed L, Thabane L, Askie L, Smith M, Farid-Kapadia M, Williamson PR, Szatmari P, Tugwell P, Golub RM, Monga S, Vohra S, Marlin S, Ungar WJ, Offringa M. JAMA 328(22):2252-2264. PMID: 36511921. [OSF archive includes research materials]
Guidelines for reporting outcomes in trial protocols: The SPIRIT-Outcomes 2022 extensionButcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, Terwee CB, Chee-A-Tow A, Baba A, Gavin F, Grimshaw JM, Kelly LE, Saeed L, Thabane L, Askie L, Smith M, Farid-Kapadia M, Williamson PR, Szatmari P, Tugwell P, Golub RM, Monga S, Vohra S, Marlin S, Ungar WJ, Offringa M. JAMA 328(23):2345-2356. PMID: 36512367. [OSF archive includes research materials]
Feasibility of an audit and feedback intervention to facilitate journal policy change towards greater promotion of transparency and openness in sports science researchHansford HJ, Cashin AG, Bagg MK, Wewege MA, Ferraro MC, Kianersi S, Mayo-Wilson E, Grant SP, Toomey E, Skinner IW, McAuley JH, Lee H, Jones MD. Sports Med Open 8(1):101. PMID: 35932429. [OSF archive includes data and code]
Open and transparent sports science research: The role of journals to move the field forwardHansford HJ, Cashin AG, Wewege MA, Ferraro MC, McAuley JH, Jones MD, and the TOP Sport Science Collaborators (contributor). Knee Surg Sports Traumatol Arthrosc 30(11):3599-3601. PMID: 35092443.
Letter report on review of Department of Veterans Affairs monograph on the economic impact and cost effectiveness of service dogs on veterans with post traumatic stress disorderNational Academies of Sciences, Engineering, and Medicine. Washington, DC: The National Academies Press. DOI: 10.17226/26353.
2021
Peer review reduces spin in PCORI research reportsMayo-Wilson E, Phillips ML, Connor AE, Vander Ley KJ, Naaman K, Helfand M. Res Integr Peer Rev 6(1):16. PMID: 34847946. [Preprint on MetaArXiv; OSF archive includes data and research materials]
Should e-cigarette regulation be based on randomized trials or observational studies?Mayo-Wilson E. Am J Public Health 111(2):219-220. PMID: 33439718.
Restoring invisible and abandoned trials of gabapentin for neuropathic pain: A clinical and methodological investigation Mayo-Wilson E, Chen X, Qureshi R, Dickinson SL, Golzarri-Arroyo L, Hong H, Görg C, Li T. BMJ Open 11(6):e047785. PMID: 34193496.
Evaluating implementation of the Transparency and Openness Promotion (TOP) Guidelines: The TRUST Process for rating journal policies, procedures, and practicesMayo-Wilson E, Grant S, Supplee L, Kianersi S, Amin A, DeHaven AC, Mellor DT. Res Integr Peer Rev 6(1):9. PMID: 34078479. [Preprint on MetaArXiv; OSF archive includes research materials]
Creating a program to support registering and reporting clinical trials at Johns Hopkins UniversityKeyes A, Mayo-Wilson E, Nuamah P, Lalji A, Tetteh O, Ford DE. Acad Med 96(4):529-533. PMID: 33060401.
Adding procedures and standards to the HomVEE review handbook on the transparency, openness, and reproducibility of research on home visiting modelsGrant SP, Mayo-Wilson E, Supplee LH. MetaArXiv. DOI: 10.31222/osf.io/7b9qj.
Adding standards and procedures to the Prevention Services Clearinghouse handbook on the transparency, openness, and reproducibility of research on programs and services to enhance support for children and families and prevent foster care placementsGrant SP, Mayo-Wilson E, Supplee LH. MetaArXiv. DOI: 10.31222/osf.io/72mc6.
Data management in substance use disorder treatment research: Implications from data harmonization of National Institute on Drug Abuse-funded randomized controlled trialsSusukida R, Amin-Esmaeili M, Mayo-Wilson E, Mojtabai R. Clin Trials 18(2):215-225. PMID: 33258697.
Development of a checklist to detect errors in meta-analyses in systematic reviews of interventions: Study protocolKanukula R, Page MJ, Dwan K, Turner SL, Loder E, Mayo-Wilson E, Li T, Misra A, McDonald S, Forbes AB, McKenzie JE. F1000Res 10:455. PMID: 34249342.
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsPage MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. BMJ 372:n71. PMID: 33782057. [Preprint on MetaArXiv]
This article was published simultaneously in:
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsPage MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. Syst Rev 10(1):89. PMID: 33781348.
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsPage MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. Int J Surg 88:105906. PMID: 33789826.
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsPage MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. PLoS Med 18(3):e1003583. PMID: 33780438.
The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsPage MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. J Clin Epidemiol 134:178-189. PMID: 33789819.
PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviewsPage MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE. BMJ 372:n160. PMID: 33781993. [Preprint on MetaArXiv]
Letter report on review of Department of Veterans Affairs monograph on potential therapeutic effects of service and emotional support dogs on veterans with post traumatic stress disorderNational Academies of Sciences, Engineering, and Medicine. Washington, DC: The National Academies Press. DOI: 10.17226/26039.
Evaluation of journal policies to increase promotion of transparency and openness in sport science researchHansford HJ, Cashin AG, Wewege MA, Ferraro MC, McAuley JH, Jones MD, and the TOP Sport Science Collaborators (contributor). J Sci Med Sport 25(2):192-194. PMID: 34474960.
This article was published simultaneously in:
- Evaluation of journal policies to increase promotion of transparency and openness in sport science researchHansford HJ, Cashin AG, Wewege MA, Ferraro MC, McAuley JH, Jones MD, and the TOP Sport Science Collaborators (contributor). Arthroscopy 37(11):3223-3225. PMID: 34740399.
2020
Time from submission of Johns Hopkins University trial results to posting on ClinicalTrials.govKeyes A, Mayo-Wilson E, Atri N, Lalji A, Nuamah PS, Tetteh O, Ford DE. JAMA Intern Med 180(2):317-319. PMID: 31657841. [OSF archive includes data and code]
Improving open and rigorous science: Ten key future research opportunities related to rigor, reproducibility, and transparency in scientific researchValdez D, Vorland CJ, Brown AW, Mayo-Wilson E, Otten J, Ball R, Grant S, Levy R, Svetina Valdivia D, Allison DB. F1000Res 9:1235. PMID: 33628434.
Toward fulfilling the aspirational goal of science as self-correcting: A call for editorial courage and diligence for error correctionVorland CJ, Brown AW, Ejima K, Mayo-Wilson E, Valdez D, Allison DB. Eur J Clin Invest 50(2):e13190. PMID: 31788792.
Mapping outcome reporting bias in published non-pharmacological randomized trials: A protocol for a cross-sectional studyHelal L, da Costa GG, de Lucena CP, Luizeti BO, Frecci GW, Gonçalves LS, Nascimento DP, Rice D, Mayo-Wilson E, Hoffmann T. MetaArXiv. DOI: 10.31222/osf.io/uegmb.
Reporting of methodological studies in health research: A protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC)Lawson DO, Puljak L, Pieper D, Schandelmaier S, Collins GS, Brignardello-Petersen R, Moher D, Tugwell P, Welch VA, Samaan Z, Thombs BD, Nørskov AK, Jakobsen JC, Allison DB, Mayo-Wilson E, Young T, Chan AW, Briel M, Guyatt GH, Thabane L, Mbuagbaw L. BMJ Open 10(12):e040478. PMID: 33334836. [Protocol on OSF]
2019
Transparent reporting: Registrations, protocols, and final reports. In: Cooper H, Hedges LV, Valentine JC, eds. The Handbook of Research Synthesis and Meta-Analysis. 3rd edMayo-Wilson E, Grant SP. Russell Sage Foundation: New York. pp. 471-488. ISBN: 978-0-87154-005-8. DOI: 10.7758/9781610448864.24.
Harms are assessed inconsistently and reported inadequately Part 2: Nonsystematic adverse eventsMayo-Wilson E, Fusco N, Li T, Hong H, Canner JK, Dickersin K, for the MUDS investigators. J Clin Epidemiol 113:11-19. PMID: 31055176. [Published protocol; Dryad archive includes data and code]
Harms are assessed inconsistently and reported inadequately Part 1: Systematic adverse eventsMayo-Wilson E, Fusco N, Li T, Hong H, Canner JK, Dickersin K, for the MUDS investigators. J Clin Epidemiol 113:20-27. PMID: 31055175. [Published protocol; Dryad archive includes data and code]
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse eventsMayo-Wilson E, Fusco N, Hong H, Li T, Canner JK, Dickersin K. Trials 20(1):553. PMID: 31488200. [Published protocol; Dryad archive includes data and code]
The selection of comparators for randomized controlled trials of health-related behavioral interventions: Recommendations of an NIH expert panelFreedland KE, King AC, Ambrosius WT, Mayo-Wilson E, Mohr DC, Czajkowski SM, Thabane L, Collins LM, Rebok GW, Treweek SP, Cook TD, Edinger JD, Stoney CM, Campo RA, Young-Hyman D, Riley WT, for the National Institutes of Health Office of Behavioral and Social Sciences Research Expert Panel on Comparator Group Selection in Behavioral and Social Science Clinical Trials. J Clin Epidemiol 110:74-81. PMID: 30826377.
Practical guidance for involving stakeholders in health researchConcannon TW, Grant SP, Welch V, Petkovic J, Selby J, Crowe S, Synnot A, Greer-Smith R, Mayo-Wilson E, Tambor E, Tugwell P, for the Multi Stakeholder Engagement (MuSE) Consortium. J Gen Intern Med 34(3):458-463. PMID: 30565151.
2018
Clinical trial registration and reporting: A survey of academic organizations in the United StatesMayo-Wilson E, Heyward J, Keyes A, Reynolds J, White S, Atri N, Alexander GC, Omar A, Ford DE on behalf of the National Clinical Trials Registration and Results Reporting Taskforce Survey Subcommittee. BMC Med 16(1):60. PMID: 29716585.
Practical guidance for using multiple data sources in systematic reviews and meta-analyses (with examples from the MUDS study)Mayo-Wilson E, Li T, Fusco N, Dickersin K, for the MUDS investigators. Res Synth Methods 9(1):2-12. PMID: 29057573.
Challenges stemming from NIH's extended registration and reporting requirementsMayo-Wilson E, Dickersin K. Nat Hum Behav 2(2):97. DOI: 10.1038/s41562-017-0286-z.
Methods to identify and prioritize patient-centered outcomes for use in comparative effectiveness researchMayo-Wilson E, Golozar A, Cowley T, Fusco N, Gresham G, Haythornthwaite JA, Tolbert E, Payne JL, Rosman L, Hutfless S, Canner JK, Dickersin K. Pilot Feasibility Stud 4:95. PMID: 30026961. [Published protocol; Dryad archive includes data and code]
Standards for design and measurement would make clinical research reproducible and usableDickersin K, Mayo-Wilson E. Proc Natl Acad Sci U S A 115(11):2590-2594. PMID: 29531086.
The benefits and challenges of using multiple sources of information about clinical trialsDickersin K, Mayo-Wilson E, Li T. Patient-Centered Outcomes Research Institute (peer reviewed final research report). PMID: 37043591. [Published protocol]
CONSORT-SPI 2018 explanation and elaboration: Guidance for reporting social and psychological intervention trialsGrant SP, Mayo-Wilson E, Montgomery P, Macdonald G, Michie S, Hopewell S, Moher D on behalf of the CONSORT–SPI Group. Trials 19(1):406. PMID: 30060763. [Published protocol; ReShare archive includes data]
Caveat emptor: The combined effects of multiplicity and selective reportingLi T, Mayo-Wilson E, Fusco N, Hong H, Dickersin K. Trials 19(1):497. PMID: 30223876.
Reporting randomised trials of social and psychological interventions: The CONSORT-SPI 2018 extensionMontgomery P, Grant SP, Mayo-Wilson E, Macdonald G, Michie S, Hopewell S, Moher D on behalf of the CONSORT –SPI Group. Trials 19(1):407. PMID: 30060754. [Published protocol; ReShare archive includes data]
Journal article reporting standards for quantitative research in psychology: The APA Publications and Communications Board task force reportAppelbaum M, Cooper H, Kline RB, Mayo-Wilson E (order of authorship is alphabetical), Nezu AM, Rao SM. Am Psychol 73(1):3-25. PMID: 29345484.
Intent of reporting standards: Reply to Rossiter (2018)Appelbaum M, Cooper H, Kline RB, Mayo-Wilson E, Nezu AM, Rao SM. Am Psychol 73(7):932. PMID: 30284892.
Making science transparent by default; introducing the TOP statementAalbersberg I, Appleyard T, Brookhart S, Carpenter T, Clarke M, Curry S, Dahl J, DeHaven A, Eich E, Franko M, Freedman L, Graf C, Grant S, Hanson B, Joseph H, Kiermer V, Kramer B, Kraut A, Karn RK, Lee C, MacFarlane A, Martone M, Mayo-Wilson E (order of authorship is alphabetical), McNutt M, McPhail M, Mellor D, Moher D, Mudditt A, Nosek B, Orland B, Parker T, Parsons M, Patterson M, Santos S, Shore C, Simons D, Spellman B, Spies J, Spitzer M, Stodden V, Swaminathan S, Sweet D, Tsui A, Vazire S. OSF Preprints. DOI: 10.17605/OSF.IO/SM78T.
2017
Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacyMayo-Wilson E, Li T, Fusco N, Bertizzolo L, Canner JK, Cowley T, Doshi P, Ehmsen J, Gresham G, Guo N, Haythornthwaite JA, Heyward J, Hong H, Pham D, Payne JL, Rosman L, Stuart EA, Suarez-Cuervo C, Tolbert E, Twose C, Vedula S, Dickersin K. J Clin Epidemiol 91:95-110.PMID: 28842290. [Published protocol; Dryad archive includes data and code]
Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesisMayo-Wilson E, Fusco N, Li T, Hong H, Canner JK, Dickersin K, for the MUDS Investigators. J Clin Epidemiol 86:39-50. PMID: 28529187. [Published protocol; Dryad archive includes data and code]
The quality of systematic reviews about interventions for refractive error can be improved: A review of systematic reviewsMayo-Wilson E, Ng SM, Chuck RS, Li T. BMC Ophthalmol 17(1):164. PMID: 28870179. [Data included in Additional file 1, Additional file 2, Additional file 3]
Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of ageImdad A, Mayo-Wilson E, Herzer K, Bhutta ZA. Cochrane Database Syst Rev 3:CD008524. PMID: 28282701. [Published protocol]
2016
Improving transparency and reproducibility through registration: The status of intervention trials published in clinical psychology journalsCybulski L, Mayo-Wilson E, Grant S. J Consult Clin Psychol 84(9):753-767. PMID: 27281372. [Supplemental Data; OSF archive includes data and research materials]
Psychological interventions for adults with bipolar disorder: Systematic review and meta-analysisOud M, Mayo-Wilson E, Braidwood R, Schulte P, Jones SH, Morriss R, Kupka R, Cuijpers P, Kendall T. Br J Psychiatry 208(3):213-222. PMID: 26932483.
NICE guidance: Why not clozapine for treatment-refractory bipolar disorder? - Authors' replyMorriss R, Mayo-Wilson E, Kendall T. Lancet Psychiatry 3(6):503. PMID: 27262048.
Implementing quality improvement for psychosocial interventionsGrant SP, Mayo-Wilson E, Montgomery P. JAMA 315(9):943. PMID: 26934268.
Scientific reporting, raising the standardsMcLeroy KR, Garney W, Mayo-Wilson E, Grant S. Health Educ Behav 43(5):501-508. PMID: 27624441.
2015
Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: A protocolMayo-Wilson E, Hutfless S, Li T, Gresham G, Fusco N, Ehmsen J, Heyward J, Vedula S, Lock D, Haythornthwaite J, Payne JL, Cowley T, Tolbert E, Rosman L, Twose C, Stuart EA, Hong H, Doshi P, Suarez-Cuervo C, Singh S, Dickersin K. Syst Rev 4:143. PMID: 26525044.
Heightened risk of false positives in a network meta-analysis of social anxiety—Author's replyMayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, Ades AE, Pilling S. Lancet Psychiatry 2(4):293-294. PMID: 26360072.
Are manufacturers sharing data as promised?Mayo-Wilson E, Doshi P, Dickersin K. BMJ 351:h4169. PMID: 26407814.
Randomized controlled trials and evidence-based practiceMontgomery P, Mayo-Wilson E. In Kevin Corcoran & Albert R. Roberts (Ed.), Social Workers' Desk Reference (pp. 1221-1229). Oxford University Press: Oxford. ISBN: 9780199329649.
Treatments for social anxiety disorder: Considerations regarding psychodynamic therapy findingsHofmann SG, Barlow DH, Clark DM, Hollon SD, Mayo-Wilson E. Am J Psychiatry 172(4):393. PMID: 25827035.
Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trialsClarke K, Mayo-Wilson E, Kenny J, Pilling S. Clin Psychol Rev 39:58-70. PMID: 25939032.
The cost effectiveness of psychological and pharmacological interventions for social anxiety disorder: A model-based economic analysisMavranezouli I, Mayo-Wilson E, Dias S, Kew K, Clark DM, Ades AE, Pilling S. PLoS One 10(10):e0140704. PMID: 26506554.
Efficacy and safety of pharmacological and psychological interventions for the treatment of psychosis and schizophrenia in children, adolescents and young adults: A systematic review and meta-analysisStafford MR, Mayo-Wilson E, Loucas CE, James A, Hollis C, Birchwood M, Kendall T. PLoS One 10(2):e0117166. PMID: 25671707.
Interventions to improve the experience of caring for people with severe mental illness: Systematic review and meta-analysisYesufu-Udechuku A, Harrison B, Mayo-Wilson E, Young N, Woodhams P, Shiers D, Kuipers E, Kendall T. Br J Psychiatry 206(4):268-274. PMID: 25833867.
Are restorative justice conferences effective in reducing repeat offending? Findings from a Campbell systematic reviewSherman LW, Strang H, Mayo-Wilson E, Woods DJ, Ariel B. J Quant Criminol 31(1):1-24. DOI: 10.1007/s10940-014-9222-9. [Published protocol]
Simultaneous synthesis of treatment effects and mapping to a common scale: An alternative to standardisationAdes AE, Lu G, Dias S, Mayo-Wilson E, Kounali D. Res Synth Methods 6(1):96-107. PMID: 26035473.
Development, inter-rater reliability and feasibility of a checklist to assess implementation (Ch-IMP) in systematic reviews: The case of provider-based prevention and treatment programs targeting children and youthCargo M, Stankov I, Thomas J, Saini M, Rogers P, Mayo-Wilson E, Hannes K. BMC Med Res Methodol 15:73. PMID: 26346461.
Promoting an open research cultureNosek BA, Alter G, Banks GC, Borsboom D, Bowman SD, Breckler SJ, Buck S, Chambers CD, Chin G, Christensen G, Contestabile M, Dafoe A, Eich E, Freese J, Glennerster R, Goroff D, Green DP, Hesse B, Humphreys M, Ishiyama J, Karlan D, Kraut A, Lupia A, Mabry PL, Madon TA, Malhotra N, Mayo-Wilson E (order of authorship is alphabetical after the first author), McNutt M, Miguel E, Paluck EL, Simonsohn U, Soderberg C, Spellman BA, Turitto J, VandenBos G, Vazire S, Wagenmakers EJ, Wilson RK, Yarkoni T. Science 348(6242):1422-1425. PMID: 26113702. [OSF archive includes research materials]
2014
Psychological and pharmacological interventions for social anxiety disorder in adults: A systematic review and network meta-analysisMayo-Wilson E, Dias S, Mavranezouli I, Kew K, Clark DM, Ades AE, Pilling S. Lancet Psychiatry 1(5):368-376. PMID: 26361000. [Registered protocol; Data and code in Appendix A and Appendix B]
Preventive home visits for mortality, morbidity, and institutionalization in older adults: A systematic review and meta-analysisMayo-Wilson E, Grant SP, Burton J, Parsons A, Underhill K, Montgomery P. PLoS One 9(3):e89257. PMID: 24622676. [Published protocol]
Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of ageMayo-Wilson E, Junior JA, Imdad A, Dean S, Chan XH, Chan ES, Jaswal A, Bhutta ZA. Cochrane Database Syst Rev 5:CD009384. PMID: 24826920. [Published protocol]
Preventive zinc supplementation for children, and the effect of additional iron: A systematic review and meta-analysisMayo-Wilson E, Imdad A, Junior J, Dean S, Bhutta ZA. BMJ Open 4(6):e004647. PMID: 24948745. [Published protocol]
Trial registration: Understanding and preventing bias in social work researchHarrison B, Mayo-Wilson E. Res Soc Work Pract 24(3):372-376. DOI: 10.1177/1049731513512374.
Centre-based day care for children younger than five years of age in low- and middle-income countriesBrown TW, van Urk FC, Waller R, Mayo-Wilson E. Cochrane Database Syst Rev 9:CD010543. PMID: 25254354. [Published protocol]
Centre-based day care for children younger than five years of age in high-income countriesvan Urk FC, Brown TW, Waller R, Mayo-Wilson E. Cochrane Database Syst Rev 9:CD010544. PMID: 25247266. [Published protocol]
Home visits for prevention of impairment and death in older adults: A systematic reviewGrant SP, Parsons A, Burton J, Montgomery P, Underhill K, Mayo-Wilson E. Campbell Syst Rev 10(1). DOI: 10.4073/csr.2014.3. [Published protocol]
A systematic review and meta-analysis of randomised controlled trials of peer support for people with severe mental illnessLloyd-Evans B, Mayo-Wilson E, Harrison B, Istead H, Brown E, Pilling S, Johnson S, Kendall T. BMC Psychiatry 14:39. PMID: 24528545.
Assessment and management of bipolar disorder: Summary of updated NICE guidanceKendall T, Morriss R, Mayo-Wilson E, Marcus E, for the Guideline Development Group of the National Institute for Health and Care Excellence. BMJ 349:g5673. PMID: 25258392.
Bipolar disorder: The assessment and management of bipolar disorder in adults, children and young people in primary and secondary careMorriss R, Kendall T, Braidwood R, Byng R, Cipriani A, James A, John C, Jones S, Legett K, Marcus E, Mavranezouli I, Mayo-Wilson E, McDougall T, Meyer T, Paton C, Stockton S, Schwannauer M, Swinden D, Taylor C, Westhead R, Whittington C, Wilson F. National Collaborating Centre for Mental Health. Royal College of Psychiatrists: London. PMID: 29718639.
Psychosis and schizophrenia in adults: The NICE guideline on the treatment and management of psychosis and schizophrenia in adultsKuipers E, Kendall T, Yesufu-Udechuku A, Slade E, Birchwood M, Brabban A, Cheema N, Green D, Harrison B, Iqbal Z, Johnson S, Marshall M, Mayo-Wilson E, Mitchell J, Morrison T, Moulin M, Shiers D, Stockton S, Taylor C, Travis C, Waddingham R, Woodhams P, Young N. National Collaborating Centre for Mental Health. Royal College of Psychiatrists: London. PMID: 25340235.
2013
Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adultsMayo-Wilson E, Montgomery P. Cochrane Database Syst Rev 9:CD005330. PMID: 24018460. [Published protocol]
Developing a reporting guideline for social and psychological intervention trialsMayo-Wilson E, Montgomery P, Hopewell S, Macdonald G, Moher D, Grant SP. Br J Psychiatry 203(3):250-254. PMID: 24029534.
This article was published simultaneously in:
Developing a reporting guideline for social and psychological intervention trialsMayo-Wilson E, Grant SP, Hopewell S, Macdonald G, Moher D, Montgomery P. Trials 14:242. PMID: 23915044.
Developing a reporting guideline for social and psychological intervention trialsGrant SP, Mayo-Wilson E, Hopewell S, Macdonald G, Moher D, Montgomery P. J Exp Criminol 9(3):355-367. DOI: 10.1007/s11292-013-9180-5.
Developing a reporting guideline for social and psychological intervention trialsMontgomery P, Mayo-Wilson E, Hopewell S, Macdonald G, Moher D, Grant SP. Am J Public Health 103(10):1741-1746. PMID: 23947317.
Developing a reporting guideline for social and psychological intervention trialsMontgomery P, Grant SP, Hopewell S, Macdonald G, Moher D, Mayo-Wilson E. Br J Soc Work 43(5):1024-1038. DOI: 10.1093/bjsw/bct129.
Developing a reporting guideline for social and psychological intervention trialsGrant SP, Montgomery P, Hopewell S, Macdonald G, Moher D, Mayo-Wilson E. Res Soc Work Pract 23(6):595-602. PMID: 25076832.
Vitamin A supplementation in Indian childrenMayo-Wilson E, Imdad A, Herzer K, Bhutta ZA. Lancet 382(9892):594. PMID: 23953382.
Apparent discrepancy between published study of gabapentin treatment and internal company reportMayo-Wilson E. J Clin Psychiatry 74(8):853-854. PMID: 24021509.
The Oxford Implementation Index: A new tool for incorporating implementation data into systematic reviews and meta-analysesMontgomery P, Underhill K, Gardner F, Operario D, Mayo-Wilson E. J Clin Epidemiol 66(8):874-882. PMID: 23810026.
Protocol for CONSORT-SPI: An extension for social and psychological interventionsMontgomery P, Grant SP, Hopewell S, Macdonald G, Moher D, Michie S, Mayo-Wilson E. Implement Sci 8:99. PMID: 24004579.
Recognition, assessment and treatment of social anxiety disorder: Summary of NICE guidancePilling S, Mayo-Wilson E, Mavranezouli I, Kew K, Taylor C, Clark DM, for the Guideline Development Group. BMJ 346:f2541. PMID: 23697669.
Reporting quality of social and psychological intervention trials: A systematic review of reporting guidelines and trial publicationsGrant SP, Mayo-Wilson E, Melendez-Torres GJ, Montgomery P. PLoS One 8(5):e65442. PMID: 23734256.
New guidelines are needed to improve the reporting of trials in addiction sciencesGrant SP, Mayo-Wilson E, Hopewell S, Macdonald G, Moher D, Montgomery P. Addiction 108(9):1687-1688. PMID: 23796394.
The need for new guidelines to improve the reporting of trials in child and adolescent mental healthGardner F, Mayo-Wilson E, Montgomery P, Hopewell S, Macdonald G, Moher D, Grant SP. J Child Psychol Psychiatry 54(7):810-812. PMID: 23789914.
Restorative justice conferencing (RJC) using face-to-face meetings of offenders and victims: Effects on offender recidivism and victim satisfactionStrang H, Sherman LW, Mayo-Wilson E, Woods DJ, Ariel B. Campbell Syst Rev 9(1). DOI: 10.4073/csr.2013.12. [Published protocol]
Early interventions to prevent psychosis: Systematic review and meta-analysisStafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. BMJ 346:f185. PMID: 23335473.
Social anxiety disorder: The NICE guideline on the recognition, assessment and treatment of social anxiety disorderClark DM, Pilling S, Mayo-Wilson E, Mavranezouli I, Afghan S, Anigbogu B, Armstrong P, Bennett M, Cartwright-Hatton S, Creswell C, Dix M, Hanlon N, Kew K, Leggett K, Malizia A, Roberts J, Satrettin K, Smith M, Stephens G, Stopa L, Stockton S, Taylor C, Whittington C. National Collaborating Centre for Mental Health. Royal College of Psychiatrists: London. PMID: 25577940.
2012
School-based mentoring for adolescents: A systematic review and meta-analysisWood S, Mayo-Wilson E. Res Soc Work Pract 22(3):257-269. DOI: 10.1177/1049731511430836.
Police strategies to reduce illegal possession and carrying of firearms: Effects on gun crimeKoper C, Mayo-Wilson E. Campbell Syst Rev 8(1). DOI: 10.4073/csr.2012.11. [Published protocol]
Development of a CONSORT extension for interventions in public health and related disciplinesGrant SP, Montgomery P, Mayo-Wilson E. Lancet 380:S14. DOI: 10.1016/S0140-6736(13)60370-0.
2011
Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: Systematic review and meta-analysisMayo-Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA. BMJ 343:d5094. PMID: 21868478. [Published protocol]
Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of ageMayo-Wilson E, Imdad A, Herzer K, Yakoob MY, Bhutta ZA. J Evid Based Med 4(2):141. DOI: 10.1111/j.1756-5391.2011.01129.x. [Published protocol]
CONSORT-EHEALTH: Improving and standardizing evaluation reports of Web-based and mobile health interventionsEysenbach G, CONSORT-EHEALTH Group (Moher D, Ritterband L, Christensen H, Stoner S, Drozd F, Blankers M, Crutzen R, Tait R, Mohr D, Evans D, Kok R, Chumnanvej S, Kooprasertying P, Anthony S, Kivuti LW, Hambly K, Aarts JW, Prins J, De la Torre I, Cook R, Jung BC, Burkhard R, Ruiz-Baques A, Gabarron E, Ahmadvand A, Gentles S, Kauer S, Kristjánsdóttir ÓB, Choubisa R, Achampong EK, Arvidsson D, Gagnon MP, Gurgan M, Daviss S, Mathieu E, Labrecque M, Anders HG, Lehto T, Kaldoudi E, Klovning A, Chih MY, Antypas K, Eide H, Lewin T, Leung FL, Ancker J, Fernando J, Archambault PM, Dias R, Lau A, Beck P, Mayo-Wilson E, Bewick B. J Med Internet Res 13(4):e126. PMID: 22209829.
2010
Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of ageImdad A, Herzer K, Mayo-Wilson E, Yakoob MY, Bhutta ZA. Cochrane Database Syst Rev 12:CD008524. PMID: 21154399. [Published protocol]
2008
Personal assistance for children and adolescents (0-18) with both physical and intellectual impairmentsMayo-Wilson E, Montgomery P, Dennis JA. Cochrane Database Syst Rev 3:CD006859. PMID: 18646173. [Published protocol]
Personal assistance for children and adolescents (0-18) with intellectual impairmentsMayo-Wilson E, Montgomery P, Dennis JA. Cochrane Database Syst Rev 3:CD006858. PMID: 18646172. [Published protocol]
Personal assistance for adults (19-64) with physical impairmentsMayo-Wilson E, Montgomery P, Dennis JA. Cochrane Database Syst Rev 3:CD006856. PMID: 18646171. [Published protocol]
Personal assistance for adults (19-64) with both physical and intellectual impairmentsMayo-Wilson E, Montgomery P, Dennis JA. Cochrane Database Syst Rev 2:CD006860. PMID: 18425973. [Published protocol]
Personal assistance for older adults (65+) without dementiaMontgomery P, Mayo-Wilson E, Dennis JA. Cochrane Database Syst Rev 1:CD006855. PMID: 18254118. [Published protocol]
Personal assistance for children and adolescents (0-18) with physical impairmentsMontgomery P, Mayo-Wilson E, Dennis JA. Cochrane Database Syst Rev 3:CD006277. PMID: 18646141. [Published protocol]
Randomized controlled trials and evidence-based practiceMontgomery P, Mayo-Wilson E. In Albert R. Roberts (Ed.), Social Workers' Desk Reference (pp. 1142-1148). Oxford University Press: Oxford. ISBN: 9780195369373.
2007
Reporting implementation in randomized trials: Proposed additions to the Consolidated Standards of Reporting Trials statementMayo-Wilson E. Am J Public Health 97(4):630-633. PMID: 17329641.
2006
Police crackdowns on illegal gun carrying: A systematic review of their impact on gun crimeKoper C, Mayo-Wilson E. J Exp Criminol 2(2):227-261. DOI: 10.1007/s11292-006-9005-x. [Published protocol]
2005
Can electronic monitoring reduce crime for moderate to high-risk offenders?Renzema M, Mayo-Wilson E. J Exp Criminol 1(2):215-237. DOI: 10.1007/s11292-005-1615-1.